RADIANT-CERSI
The DigitalHealth.London RADIANT-CERSI Innovator Support Programme is designed to improve understanding of the regulatory landscape and compliance process for Software as a Medical Device (SaMD) and Artificial Intelligence as a Medical Device (AIaMD), with the goal of supporting valuable UK medical innovations to reach the market safely and efficiently.
Who is the RADIANT-CERSI DigitalHealth.London Innovator Support Programme for?
The online programme is designed for UK-based start-up companies, with a technology that is either a software as a medical device (SaMD) or an artificial intelligence as a medical device (AIaMD). The technology can be any class (I, IIa, IIb, III) but must have a technology readiness level of 4 or above.
The first cohort of this fully-funded programme was delivered between Monday 16 June 2025 and Sunday 2 October 2025. Click to read a collaborative blog with RADIANT-CERSI to learn more about the programme design, its impact so far and key learnings from the cohort that will shape the future of regulation.
The DigitalHealth.London RADIANT-CERSI Innovator Support programme was delivered by DigitalHealth.London and the Health Innovation Network South London, in partnership with RADIANT-CERSI and experts in regulation.
RADIANT-CERSI is one of seven Centre of Excellence in Regulatory Science and Innovation (CERSI) in Transformative Digital Health and AI across the UK.
It is funded by Innovate UK, in partnership with the Medical Research Council, the Medicines and Healthcare Products Regulatory Agency (MHRA) and the Office for Life Sciences (OLS).
RADIANT-CERSI is led by Brunel University of London, with partners across healthcare, research and academia, including the Health Innovation Network South London, Helix Data Innovation, Zinc, UCL, Imperial College Healthcare NHS Trust, King’s College London and BMJ.
What’s involved?
During the first cohort, a series of online workshops supported digital health companies by:
- Improving understanding on how to navigate current regulatory requirements for SaMD and AIaMD.
- Providing knowledge and guidance on how to direct the development and evaluation of digital health solutions.
- Offering information and practical advice on how to plan regulatory compliance activities.
- Facilitating opportunities to hear from peers, experts and stakeholders.
- Assisting with access to further resources and networking through the wider RADIANT-CERSI.
Case studies
Browse case studies from the first cohort of the RADIANT-CERSI DigitalHealth.London Innovator Support programme and learn more about how participants were supported to enhance their understanding of the regulatory landscape and compliance process for Software as a Medical Device (SaMD) and Artificial Intelligence as a Medical Device (AIaMD).
RADIANT-CERSI Innovator Support programme: Omnilabs Research accelerates regulatory roadmap through expert-led support
Lucie Legrandoisshares shares how the programme served as a catalyst for initiating Omnilabs Research’s regulatory journey.
RADIANT-CERSI Innovator Support programme: MedForce AI unlocking new opportunities for business development through enhanced regulatory knowledge
MedForceAI shares how knowledge gained through the RADIANT-CERSI Innovator Support programme unlocked business development opportunities.
RADIANT-CERSI Innovator Support programme: Suna Health turns regulatory complexity into a strategic advantage
Dr Chad Okay, Founder and CEO of Suna Health, shares how the programme transformed regulation from an impenetrable black box into a structured process.
